Holen Sie sich die Stockscreener-App
17.38
1.64%
0.28
Schlusskurs vom Vortag:
$17.10
Offen:
$17.1
24-Stunden-Volumen:
3.95M
Relative Volume:
1.23
Marktkapitalisierung:
$4.96B
Einnahmen:
$1.19B
Nettoeinkommen (Verlust:
$117.80M
KGV:
42.36
EPS:
0.4103
Netto-Cashflow:
$92.48M
1W Leistung:
+9.86%
1M Leistung:
+8.90%
6M Leistung:
-1.81%
1J Leistung:
+52.99%
1-Tages-Spanne:
$17.10
$17.40
1-Wochen-Bereich:
$15.61
$17.40
52-Wochen-Spanne:
$10.93
$19.85
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
17.38 | 4.88B | 1.19B | 117.80M | 92.48M | 0.4103 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Sotera Health shares, sector peers and risk management in focus - Ad-hoc-news.de
SHC Maintained by Barclays -- Price Target Raised to $19.00 - GuruFocus
Sotera Health Co (SHC) Institutional Confidence - TradingKey
Sotera Health Co (SHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sotera Health Co (SHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sotera Health Co (SHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sotera Health Co (SHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sotera Health Co (SHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sotera Health Co (SHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sotera Health Co Stock (US8293551086): Earnings Metrics In Focus After Recent Quarterly Update - Ad-hoc-news.de
Sotera Health (SHC) Valuation After Goldman Coverage Legal Clarity And Earnings Beat - simplywall.st
Sotera Health Co stock (US8293551086): investors eye litigation overhang and growth in sterilization - AD HOC NEWS
Did Goldman Sachs’ Legal-Risk Reassessment Just Shift Sotera Health's (SHC) Investment Narrative? - simplywall.st
SHC Initiates Coverage On by Goldman Sachs -- Price Target Annou - GuruFocus
Goldman Sachs initiates Sotera Health stock with buy rating on durable model - Investing.com
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Sotera Health Co stock (US8293551086): Nasdaq-listed sterilization group in focus after recent earni - AD HOC NEWS
Sotera Health (SHC) director Ann R. Klee granted 14,970 RSUs as equity award - Stock Titan
Sotera Health (SHC) CEO awarded large RSU and performance SAU grants - Stock Titan
Sotera Health (NYSE: SHC) CEO Alton Shader files initial insider Form 3 - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs as equity compensation - Stock Titan
Sotera Health (SHC) director Sean Cunningham receives 14,970 RSU equity grant - Stock Titan
Sotera Health (SHC) director Karen Flynn granted 14,970 RSUs as board compensation - Stock Titan
Sotera Health (SHC) director receives 14,970 RSUs in equity grant - Stock Titan
Sotera Health (SHC) awards 14,970 RSUs to director Vincent Petrella - Stock Titan
Sotera Health (SHC) director gets 14,970 RSUs, now holds 95,751 - Stock Titan
Sotera Health (SHC) director Christopher Simon receives 14,970 RSU award - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs, now holds 89,882 shares - Stock Titan
The Bull Case For Sotera Health (SHC) Could Change Following Term Loan Refinancing At Lower Interest Margin - Yahoo Finance
A Look At Sotera Health (SHC) Valuation After Strong Q1 Beat And Upgraded Full Year Outlook - Yahoo Finance
Sotera Health’s SWOT analysis: legal wins reshape stock outlook By Investing.com - Investing.com Canada
Sotera Health’s SWOT analysis: legal wins reshape stock outlook - Investing.com
Sotera Health names new CEO in planned leadership transition - MSN
Sotera Health shareholders elect directors and approve executive pay at annual meeting - Investing.com Australia
Sotera Health (NASDAQ: SHC) investors back directors, pay and auditor - Stock Titan
Q1 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Sotera Health Co Annual Shareholders Meeting Transcript - GuruFocus
DoubleVerify, Sotera Health, PROG Holdings: Stocks Under $50 to Approach With CautionNews and Statistics - IndexBox
Sotera Health (SHC) amends First Lien Credit Agreement and reprices term loans - Stock Titan
3 Stocks Under $50 We Find Risky - Yahoo Finance
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Find Risky - Yahoo Finance
JP Morgan Maintains Sotera Health (SHC) Neutral Recommendation - MSN
Sotera Health Co stock (US8293551086): litigation overhang eases as business focuses on sterilizatio - AD HOC NEWS
Sotera Health Co stock (US8293551086): Major private equity exit reshapes shareholder base - AD HOC NEWS
Major Insider Shake-Up at Sotera Health as Top Directors Unload Massive Stakes - TipRanks
Warburg Pincus entities sell $289.7m in Sotera Health stock on May 13 - Investing.com Australia
Warburg Pincus entities sell $289.7m in Sotera Health stock on May 13 By Investing.com - Investing.com South Africa
GTCR funds sell $193.2m Sotera Health Co stock - Investing.com
GTCR funds sell $193.2m Sotera Health Co stock By Investing.com - Investing.com South Africa
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sotera Health Co-Aktie (SHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| WARBURG PINCUS & CO. | Director |
May 13 '26 |
Sale |
15.17 |
19,102,952 |
289,753,576 |
0 |
| GTCR INVESTMENT XI LLC | Director |
May 13 '26 |
Sale |
15.17 |
12,735,301 |
193,169,046 |
0 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| GTCR INVESTMENT XI LLC | Director |
Mar 06 '26 |
Sale |
15.27 |
10,000,000 |
152,700,000 |
12,735,301 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
434,104 |
7,141,011 |
0 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
315,896 |
5,196,489 |
552,790 |
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):